Ascendis Pharma A/S (ASND)
244.48
+1.53
(+0.63%)
USD |
NASDAQ |
Apr 17, 16:00
244.50
+0.02
(+0.01%)
After-Hours: 20:00
Ascendis Pharma SG&A Expense (Quarterly) : 158.13M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Novo Nordisk A/S | 2.718B |
| Evaxion AS | 1.491M |
| Trinity Biotech Plc | 6.429M |
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | 12.79M |